• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者组织微阵列图像和临床结局数据的精选集。

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients.

机构信息

Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.

Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.

出版信息

Sci Data. 2017 Mar 14;4:170014. doi: 10.1038/sdata.2017.14.

DOI:10.1038/sdata.2017.14
PMID:28291248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5349242/
Abstract

Microscopy image data of human cancers provide detailed phenotypes of spatially and morphologically intact tissues at single-cell resolution, thus complementing large-scale molecular analyses, e.g., next generation sequencing or proteomic profiling. Here we describe a high-resolution tissue microarray (TMA) image dataset from a cohort of 71 prostate tissue samples, which was hybridized with bright-field dual colour chromogenic and silver in situ hybridization probes for the tumour suppressor gene PTEN. These tissue samples were digitized and supplemented with expert annotations, clinical information, statistical models of PTEN genetic status, and computer source codes. For validation, we constructed an additional TMA dataset for 424 prostate tissues, hybridized with FISH probes for PTEN, and performed survival analysis on a subset of 339 radical prostatectomy specimens with overall, disease-specific and recurrence-free survival (maximum 167 months). For application, we further produced 6,036 image patches derived from two whole slides. Our curated collection of prostate cancer data sets provides reuse potential for both biomedical and computational studies.

摘要

人类癌症的显微镜图像数据以单细胞分辨率提供了空间和形态上完整组织的详细表型,从而补充了大规模的分子分析,例如下一代测序或蛋白质组学分析。在这里,我们描述了来自 71 例前列腺组织样本队列的高分辨率组织微阵列 (TMA) 图像数据集,该数据集与用于肿瘤抑制基因 PTEN 的明场双色显色和银原位杂交探针杂交。这些组织样本经过数字化处理,并附有专家注释、临床信息、PTEN 遗传状态的统计模型和计算机源代码。为了验证,我们构建了另外一个包含 424 个前列腺组织的 TMA 数据集,并用 FISH 探针对其进行了杂交,并对包含 339 个根治性前列腺切除术标本的亚组进行了生存分析,包括总生存、疾病特异性生存和无复发生存(最长 167 个月)。为了应用,我们进一步从两个全玻片中生成了 6036 个图像补丁。我们精心整理的前列腺癌数据集为生物医学和计算研究提供了重复使用的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7eb/5349242/a76456931696/sdata201714-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7eb/5349242/246061763e58/sdata201714-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7eb/5349242/a76456931696/sdata201714-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7eb/5349242/246061763e58/sdata201714-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7eb/5349242/a76456931696/sdata201714-f2.jpg

相似文献

1
A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients.前列腺癌患者组织微阵列图像和临床结局数据的精选集。
Sci Data. 2017 Mar 14;4:170014. doi: 10.1038/sdata.2017.14.
2
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.3p13 缺失重现可靶向多个肿瘤抑制基因,并定义了一组具有独特特征的 ERG 融合阳性前列腺癌亚群。
J Pathol. 2013 Sep;231(1):130-41. doi: 10.1002/path.4223.
3
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias.在组织学切片中对PTEN进行间期荧光原位杂交分析显示,68%的原发性前列腺癌和23%的高级别前列腺上皮内瘤变存在基因组缺失。
Cancer Genet Cytogenet. 2006 Sep;169(2):128-37. doi: 10.1016/j.cancergencyto.2006.04.003.
4
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.高 RNA 结合基序蛋白 3 的表达是手术治疗的前列腺癌的一个独立预后标志物,与 ERG 激活和 PTEN 缺失密切相关。
Eur J Cancer. 2014 Mar;50(4):852-61. doi: 10.1016/j.ejca.2013.12.003. Epub 2013 Dec 28.
5
High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts.利用人工智能对组织微阵列中的生物标志物进行高通量评估:多中心前列腺癌队列中 PTEN 缺失作为原理验证。
Mod Pathol. 2021 Feb;34(2):478-489. doi: 10.1038/s41379-020-00674-w. Epub 2020 Sep 3.
6
SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.SPINK1在局限性前列腺癌中的过表达:一种与ERG表达呈负相关且排除纯合性PTEN缺失的罕见事件。
Pathol Oncol Res. 2017 Apr;23(2):399-407. doi: 10.1007/s12253-016-0119-9. Epub 2016 Oct 13.
7
Automated multiplexing quantum dots in situ hybridization assay for simultaneous detection of ERG and PTEN gene status in prostate cancer.自动化多重量子点原位杂交法检测前列腺癌中 ERG 和 PTEN 基因状态
J Mol Diagn. 2013 Nov;15(6):754-64. doi: 10.1016/j.jmoldx.2013.06.005. Epub 2013 Aug 28.
8
Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.前列腺癌中SLC18A2基因和表观遗传沉默是根治性前列腺切除术后生化复发的独立不良预测因素。
Clin Cancer Res. 2009 Feb 15;15(4):1400-10. doi: 10.1158/1078-0432.CCR-08-2268.
9
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.基于图像的基因改变和肿瘤异质性的计算量化与可视化
Sci Rep. 2016 Apr 7;6:24146. doi: 10.1038/srep24146.
10
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.小泛素样修饰蛋白1/类泛素特异性蛋白酶1(SENP1)在前列腺癌中的预后价值仅限于缺乏PTEN缺失的ERG融合阳性肿瘤。
BMC Cancer. 2015 Jul 23;15:538. doi: 10.1186/s12885-015-1555-8.

引用本文的文献

1
Enhanced hierarchical attention mechanism for mixed MIL in automatic Gleason grading and scoring.用于自动Gleason分级和评分中混合多实例学习的增强分层注意力机制
Sci Rep. 2025 May 8;15(1):15980. doi: 10.1038/s41598-025-00048-9.
2
Harnessing artificial intelligence for prostate cancer management.利用人工智能进行前列腺癌管理。
Cell Rep Med. 2024 Apr 16;5(4):101506. doi: 10.1016/j.xcrm.2024.101506. Epub 2024 Apr 8.
3
Proteomic-based stratification of intermediate-risk prostate cancer patients.基于蛋白质组学的中危前列腺癌患者分层。

本文引用的文献

1
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.基于图像的基因改变和肿瘤异质性的计算量化与可视化
Sci Rep. 2016 Apr 7;6:24146. doi: 10.1038/srep24146.
2
Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps.将组织活检样本快速质谱转化为永久性定量数字蛋白质组图谱。
Nat Med. 2015 Apr;21(4):407-13. doi: 10.1038/nm.3807. Epub 2015 Mar 2.
3
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
Life Sci Alliance. 2023 Dec 4;7(2). doi: 10.26508/lsa.202302146. Print 2024 Feb.
4
Aberrations of DNA Repair Pathways in Prostate Cancer-The State of the Art.前列腺癌中 DNA 修复途径的异常——最新进展。
Int J Mol Sci. 2023 Feb 21;24(5):4301. doi: 10.3390/ijms24054301.
5
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management.前列腺癌的临床蛋白质组学:了解前列腺癌病理学和蛋白质生物标志物以改善疾病管理。
Clin Proteomics. 2020 Nov 20;17(1):41. doi: 10.1186/s12014-020-09305-7.
6
Inferring clonal composition from multiple tumor biopsies.从多个肿瘤活检中推断克隆组成。
NPJ Syst Biol Appl. 2020 Aug 25;6(1):27. doi: 10.1038/s41540-020-00147-5.
7
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer.肿瘤内异质性决定前列腺癌 mTOR 通路蛋白的表达。
Dis Markers. 2019 Dec 11;2019:1296865. doi: 10.1155/2019/1296865. eCollection 2019.
8
Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.一种用于改善前列腺癌Gleason评分的深度学习算法的开发与验证
NPJ Digit Med. 2019 Jun 7;2:48. doi: 10.1038/s41746-019-0112-2. eCollection 2019.
9
Automated Gleason grading of prostate cancer tissue microarrays via deep learning.基于深度学习的前列腺癌组织微阵列 Gleason 分级自动化。
Sci Rep. 2018 Aug 13;8(1):12054. doi: 10.1038/s41598-018-30535-1.
前列腺癌中 GABRE~miR-452~miR-224 启动子的高甲基化预测根治性前列腺切除术后的生化复发。
Clin Cancer Res. 2014 Apr 15;20(8):2169-81. doi: 10.1158/1078-0432.CCR-13-2642.
4
SPOP mutations in prostate cancer across demographically diverse patient cohorts.前列腺癌中 SPOP 突变在不同人群患者队列中的情况。
Neoplasia. 2014 Jan;16(1):14-20. doi: 10.1593/neo.131704.
5
The Cancer Genome Atlas Pan-Cancer analysis project.癌症基因组图谱泛癌分析项目。
Nat Genet. 2013 Oct;45(10):1113-20. doi: 10.1038/ng.2764.
6
DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.用于预测局限性前列腺癌根治术后生化复发的 DNA 甲基化特征。
J Clin Oncol. 2013 Sep 10;31(26):3250-8. doi: 10.1200/JCO.2012.47.1847. Epub 2013 Aug 5.
7
TMARKER: A free software toolkit for histopathological cell counting and staining estimation.TMARKER:用于组织病理学细胞计数和染色评估的免费软件工具包。
J Pathol Inform. 2013 Mar 30;4(Suppl):S2. doi: 10.4103/2153-3539.109804. Print 2013.
8
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.定量分析乳腺肿瘤中的细胞异质性可补充基因组分析。
Sci Transl Med. 2012 Oct 24;4(157):157ra143. doi: 10.1126/scitranslmed.3004330.
9
Intratumor heterogeneity: evolution through space and time.肿瘤内异质性:时空演变。
Cancer Res. 2012 Oct 1;72(19):4875-82. doi: 10.1158/0008-5472.CAN-12-2217. Epub 2012 Sep 20.
10
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.PTEN 基因缺失与 ERG 融合阳性和融合阴性前列腺癌中肿瘤进展和早期 PSA 复发相关。
Am J Pathol. 2012 Aug;181(2):401-12. doi: 10.1016/j.ajpath.2012.04.026. Epub 2012 Jun 13.